1[1]Ishibashi Y, Sasamura Y, Ohe K, et al. A case report of mitral valve replacement for infective endocarditis in pregnancy[J]. Kyobu Geka, 1994, 47(6):474～476.
2[2]Souma T, Yokosawa T, Iwamatsu T, et al. Successful mitral valve replacement for infective endocarditis in pregnancy[J]. Nippon Kyobu Geka Gakkai Zasshi, 1990,38(6):1035～1038.
3[3]Matsumoto H, Shimokawa S, Umebyashi Y, et al. Simultaneous cesarean section and mitral valve replacement for infective endocarditis during pregnancy--a case report[J]. Nippon Kyobu Geka Gakkai Zasshi,1993,41(2):329～313.
4[4]Majumdar A, Chowdhary S, Ferreira MA, et al. Renal pathological findings in infective endocarditis[J].Nephrol Dial Transplant, 2000,15(11): 1782～1787.
5[5]Kong KH, Chan KF. Ruptured intracranial mycotic aneurysm: a rare cause of intracranial hemorrhage[J].Arch Phys Med Rehabil, 1995,76(3):287～289.
3Muretti M, Torre TM, Mauri R, et al. Mitral valve replace- ment in pregnancy., a successful strategy for fetal survival. J Heart Valve Dis, 2010,19(6) :789-791.
4Matsumoto H, Shimokawa S, Umebayashi Y, et al. Simultane- ous cesarean section and mitral valve replacement for infective endocarditis during pregnancy--a case report. Nihon Kyobu Ge- ka Gakkai Zasshi, 1993,41 (2) : 329-331.
5Mishra M,Sawhney R,Kumar A,et al. Cardiac surgery during pregnancy., continuous fetal monitoring using umbilical artery Doppler flow velocity indices. Ann Card Anaesth, 2014, 17 (1):46-51.
6Albert SG,Ariyan S,Rather A. The effect of etomidate on ad- renal function in critical illness., a systematic review. Intensive Care Med, 2011,37 (6) 901-910.
7Wagner CE, Bick JS, Johnson D, et a]. Etomi3ate use and postoperative outcomes among cardiac surgery patients. Anes- thesiology, 2014,120(3) .. 579-589.
8Budde AO,Mets ]3. Pro: etomidate is the ideal induction agent for a cardiac anesthetic. J Cardiothorac Vasc Anesth, 2013,27 (1) ..180-183.
